We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,299

CFDA’s New Draft Policy Introduces the Chinese Version of Patent Linkage
  • Allen & Overy LLP
  • China
  • May 16 2017

On May 12, Chinese Food and Drug Administration (CFDA) issued Policy Notice No. 55, entitled “Policies Relevant to the Protection of the Rights and


Australian Life Sciences and Biotech: Key themes and trends
  • Minter Ellison
  • Australia, China, Global
  • April 18 2017

The Australian life sciences and biotech sector is likely to continue its resurgence over the next twelve months, with global trends driving strong


Global Intellectual Property Newsletter - 13th Issue - IP Topics from around the Globe
  • Clifford Chance LLP
  • China, Czech Republic, France, Germany, Hong Kong, Italy, United Kingdom
  • March 13 2017

Welcome to the 13th edition of the Clifford Chance Global IP Newsletter. In this first Newsletter of 2017, our global IP Team would like to provide


SIPO amends its Patent Examination Guidelines
  • WAN HUI DA
  • China
  • March 1 2017

On March 1, 2017, the State Intellectual Property Office of China (SIPO) issued a decision to amend its Patent Examination Guidelines. The amendment


Protection of Standard-Related Patents Analysis of a Dispute Between Sihuan Pharm and Qilu Pharmaceutical
  • King & Wood Mallesons
  • China
  • February 15 2017

In January 2017, Beijing Sihuan Pharmaceutical Co., Ltd. ("Sihuan Pharm"), represented by a King & Wood Mallesons' IP litigation team, succeeded in a


涉及药品标准的专利保护以四环制药与齐鲁制药之间的专利纠纷为视角
  • King & Wood Mallesons
  • China
  • February 15 2017

2017年1月北京四环制药有限公司下称“四环制药”在金杜知识产权诉讼团队的协助下获得一起专利侵权纠纷的


Particularity in the Inventiveness Evaluation of Chemical Composition Inventions
  • Beijing East IP Ltd
  • China
  • February 13 2017

Nippon Steel &Sumikin Stainless Steel v. The Patent Reexamination Board of SIPO (Administrative Judgement (2013) GAO Xing Zhong Zi No. 1754 by


Dentons' pick of global regulatory trends to watch in 2017
  • Dentons
  • Australia, Canada, China, European Union, Germany, Mexico, OECD, United Kingdom, USA
  • February 9 2017

Dentons’ team of regulatory lawyers from key jurisdictions around the world weigh in on regulatory trends to watch in 2017 in the US, Europe, the UK


Competitionantitrust law
  • Dentons
  • USA, Canada, China, European Union, Germany, OECD, United Kingdom, Australia
  • February 9 2017

In the wake of the 2016 elections, we now await the decision as to who will be the "antitrust guard" at the top of the US Department


中国知識産権局専利復審委員会 の復審無効事例紹介(2015)-2
  • King & Wood Mallesons
  • China
  • January 24 2017

前回に続き中国知識産権局専利復審委員会による2015年の復審無効十大判例のうち化学生物医薬分野の審決の概要と解説を行う